Catherine Pachuk, Ph.D.
Assistant Adjunct Professor (Adjunct Faculty) 



(1988) University of Pennsylvania, Ph.D, Molecular Biology

(2012) Regulatory Affairs Professional Society, Dual Certificate, Medical Devices and                Pharmaceuticals

Appointment at the Baruch S. Blumberg Institute:      

Adjunct Assistant Professor of Translational Research

Other appointments:

Chief Scientific Officer/Business Unit Head at Somahlution – 2011 to present


Dr. Pachuk serves as a Chief Scientist Officer for Somahlution and is a member of the company’s Board of Directors. Dr. Pachuk has twenty-five years R&D leadership experience in the pharmaceutical and biotech sectors with expertise in drug, vaccine and medical device development. She received her Ph.D. in Molecular Virology from the University of Pennsylvania. Following a post-doctoral fellowship at SmithKline Beecham, she joined Apollon, Inc. to develop programs in oligonucleotide- based therapeutics, and subsequently DNA-based vaccines for both viral and oncology indications. Following te acquisitions of Apollon, Inc. by Wyeth-Ayerst Research in 1998 she continued to direct several vaccine programs which resulted in several products being advanced into clinical trials. In 2001, she co-founded Nucleonics, a biotech focused on the development of RNAI-based therapeutics. Until April of 2008, she was VP of Preclinical Research. Dr. Pachuk then went to lead development efforts for Pfizer’s Cambride-based oligonucleotide therapeutic Programs in the areas of Oncology and metabolic disease and was a member of the Executive Leadership Team.